Fifteen patients with nonmetastatic gestational trophoblastic disease were treated solely with methotrexate given orally rather than intramuscularly. Remission, defined as a ti-human chorionic gonadotropin titer of <5 mlU/ml for 3 consecutive weeks, was attained in 13 (87%) of the 15 patients. Level of toxicity was acceptable. Patient comfort, convenience, and less time off work and in the physician's office are significant advantages to this efficacious, well-tolerated method of therapy.
- Gestational trophoblastic disease
- oral methotrexate
ASJC Scopus subject areas
- Obstetrics and Gynecology